Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.42% | 165.87 | 0.7% | $1243.67m | |
| PFE | Pfizer Inc. | 1.97% | 37.27 | 0.9% | $1193.22m | |
| LLY | Eli Lilly & Co. | 3.09% | 212.51 | 1.1% | $1017.68m | |
| ABBV | AbbVie, Inc. | -0.54% | 110.26 | 1.9% | $759.26m | |
| MRK | Merck & Co., Inc. | 0.20% | 81.14 | 0.7% | $707.88m | |
| AZN | AstraZeneca Plc | 1.43% | 54.01 | 1.2% | $704.34m | |
| BMY | Bristol-Myers Squibb Co. | 0.42% | 64.83 | 1.0% | $702.75m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 2.57% | 69.44 | 0.0% | $238.08m | |
| VTRS | Viatris, Inc. | -1.15% | 17.23 | 0.0% | $198.15m | |
| NVS | Novartis AG | 1.66% | 98.51 | 0.2% | $189.98m | |
| GRTS | Gritstone Oncology, Inc. | -11.99% | 23.86 | 0.0% | $188.77m | |
| RPRX | Royalty Pharma Plc | 0.67% | 51.50 | 0.2% | $180.84m | |
| GSK | GlaxoSmithKline Plc | 1.43% | 38.91 | 0.2% | $162.00m | |
| SNY | Sanofi | -0.12% | 49.63 | 0.2% | $138.94m | |
| TAK | Takeda Pharmaceutical Co., Ltd. | 1.32% | 18.37 | 0.0% | $81.25m |
Company Profile
Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.